RE:CZO IS NOT DE-RISKEDSo why would J&J pull the plug on Ceapro?
Given that Ceapro is the only commercial supplier of avenantramides from oats, that would imply that;
1. J&J would use a synthetic form of AVN or
2. it would abandon their Avenno line of products.
2. is unlikely to happen, and neither is 1. as their branding of Aveeno products is the use of natural oat extracts
So why would you worry about J&J pulling the plug which has a minute possibility and your doomsday scenario saying it's finished would imply that the other 50% of the business could not support the business along with their $13M of cash while they make progress to commericalize a functional drink, scale up their Y-BG immune booster product, their AV pill study, and move Y-BG as an inhalable therapeutic.
Alex1726 wrote: That is not the case. J&J represents 50% of all sale , Gagnon told that during one of his presentation.
If J&J pull the plug it is finished.